Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Cash from Financing Activities

Arbutus Biopharma Cp Cash from Financing Activities Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Cash from Financing Activities from 2010 to 2018.
  • Arbutus Biopharma Cp Cash from Financing Activities for the quarter ending December 12, 2018 was $0m a -86,196.83% decrease of -54m year over year
  • Arbutus Biopharma Cp Cash from Financing Activities for the last 12 months ending December 12, 2018 was $56m a -85.85% decrease of -48m year over year
  • Arbutus Biopharma Cp Annual Cash from Financing Activities for 2018 was $56m a 11.33% increase of 6m from 2017
  • Arbutus Biopharma Cp Annual Cash from Financing Activities for 2017 was $49m a 74.37% increase of 37m from 2016
  • Arbutus Biopharma Cp Annual Cash from Financing Activities for 2016 was $13m a -1,038.39% decrease of -131m from 2015
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Cash from Financing Activities Data

12/2018$0m
09/2018$0m
06/2018$1m
03/2018$54m
12/2017$49m
09/2017$0m
06/2017$0m
03/2017$0m
12/2016$12m
09/2016$0m

Annual ABUS Cash from Financing Activities Data

2018$56m
2017$49m
2016$13m
2015$144m
2014$61m
2013$33m
2012$5m
2011$5m
2010$0m
2009$0m